Pediatrix Medical Group, Inc.(MD)— Stock Profile, AI Score & Financials

Healthcare · NYSE · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated 2026-06-30.

Pediatrix Medical Group, Inc. (MD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. 13F Pro's AI-powered ranking engine scores MD at 56.2/100 on a 32-signal composite quality model, placing it at rank #1,194 of 2,960 stocks — the top half of the AI-ranked universe. MD scores in the top quartile across balance sheet strength (80.9). Areas of concern include revenue growth (20.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q2 2026), Pediatrix Medical Group, Inc. reports quarterly revenue of $487.8M, net income of $39.8M, an operating margin of 11.7%. Top institutional holders of MD by reported 13-F value include BlackRock, VANGUARD PORTFOLIO MANAGEMENT, DIMENSIONAL FUND ADVISORS, based on the most recent SEC filings. MD trades on the NYSE exchange and files with the SEC under CIK 893949. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate MD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Pediatrix Medical Group, Inc. directly from SEC EDGAR.